Mesothelin-directed CAR-T cells (General Hospital of the People's Liberation Army)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameMesothelin-directed CAR-T cells (General Hospital of the People's Liberation Army)
Drug Alias NameGC-008t
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacementsAnti-Mesothelin +[4] 
TargetsMesothelinProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesPeople'S Liberation Army General Hospital Military ServiceGracell Biotechnologies (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPla General Hospital
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A